CN113292489A - Preparation method of dichlorodialkyl nicotinonitrile - Google Patents
Preparation method of dichlorodialkyl nicotinonitrile Download PDFInfo
- Publication number
- CN113292489A CN113292489A CN202110667044.XA CN202110667044A CN113292489A CN 113292489 A CN113292489 A CN 113292489A CN 202110667044 A CN202110667044 A CN 202110667044A CN 113292489 A CN113292489 A CN 113292489A
- Authority
- CN
- China
- Prior art keywords
- reaction
- compound
- iii
- controlled
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- GZPHSAQLYPIAIN-UHFFFAOYSA-N 3-pyridinecarbonitrile Chemical compound N#CC1=CC=CN=C1 GZPHSAQLYPIAIN-UHFFFAOYSA-N 0.000 title claims abstract description 12
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 claims abstract description 46
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 claims abstract description 22
- DGJMPUGMZIKDRO-UHFFFAOYSA-N cyanoacetamide Chemical compound NC(=O)CC#N DGJMPUGMZIKDRO-UHFFFAOYSA-N 0.000 claims abstract description 22
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 claims abstract description 19
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 claims abstract description 18
- 238000005660 chlorination reaction Methods 0.000 claims abstract description 18
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000000460 chlorine Substances 0.000 claims abstract description 16
- 229910052801 chlorine Inorganic materials 0.000 claims abstract description 16
- 150000001875 compounds Chemical class 0.000 claims abstract description 13
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 239000012320 chlorinating reagent Substances 0.000 claims abstract description 6
- 238000006482 condensation reaction Methods 0.000 claims abstract description 6
- 239000003513 alkali Substances 0.000 claims abstract description 3
- 238000006243 chemical reaction Methods 0.000 claims description 87
- 238000000034 method Methods 0.000 claims description 23
- 238000003756 stirring Methods 0.000 claims description 18
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 239000007787 solid Substances 0.000 claims description 12
- 238000001914 filtration Methods 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 7
- 230000035484 reaction time Effects 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 239000003960 organic solvent Substances 0.000 claims description 4
- 239000003444 phase transfer catalyst Substances 0.000 claims description 4
- 238000005406 washing Methods 0.000 claims description 4
- 238000002386 leaching Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 239000002585 base Substances 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 2
- 239000000243 solution Substances 0.000 claims description 2
- 239000012527 feed solution Substances 0.000 claims 1
- 239000007789 gas Substances 0.000 abstract description 17
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 abstract description 10
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 abstract description 5
- 239000002912 waste gas Substances 0.000 abstract description 4
- 238000003786 synthesis reaction Methods 0.000 abstract description 3
- 230000007797 corrosion Effects 0.000 abstract description 2
- 238000005260 corrosion Methods 0.000 abstract description 2
- 230000002378 acidificating effect Effects 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 33
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 24
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
- 239000000047 product Substances 0.000 description 18
- 239000011521 glass Substances 0.000 description 15
- 238000010438 heat treatment Methods 0.000 description 15
- 238000012544 monitoring process Methods 0.000 description 14
- UCGWYTUBYASPFG-UHFFFAOYSA-N 2,5-dichloro-4,6-dimethylpyridine-3-carbonitrile Chemical group CC1=NC(Cl)=C(C#N)C(C)=C1Cl UCGWYTUBYASPFG-UHFFFAOYSA-N 0.000 description 12
- YRKCREAYFQTBPV-UHFFFAOYSA-N acetylacetone Chemical compound CC(=O)CC(C)=O YRKCREAYFQTBPV-UHFFFAOYSA-N 0.000 description 12
- 239000012071 phase Substances 0.000 description 12
- 239000007791 liquid phase Substances 0.000 description 11
- VLRGXXKFHVJQOL-UHFFFAOYSA-N 3-chloropentane-2,4-dione Chemical compound CC(=O)C(Cl)C(C)=O VLRGXXKFHVJQOL-UHFFFAOYSA-N 0.000 description 10
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 10
- CEIUMKPKEXHJEN-UHFFFAOYSA-N 5-chloro-4,6-dimethyl-2-oxo-1h-pyridine-3-carbonitrile Chemical compound CC=1NC(=O)C(C#N)=C(C)C=1Cl CEIUMKPKEXHJEN-UHFFFAOYSA-N 0.000 description 9
- 239000005708 Sodium hypochlorite Substances 0.000 description 8
- 239000006227 byproduct Substances 0.000 description 8
- 238000001035 drying Methods 0.000 description 8
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 7
- 239000007864 aqueous solution Substances 0.000 description 7
- 239000007795 chemical reaction product Substances 0.000 description 7
- 238000007599 discharging Methods 0.000 description 7
- 238000005070 sampling Methods 0.000 description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- OKIZCWYLBDKLSU-UHFFFAOYSA-M N,N,N-Trimethylmethanaminium chloride Chemical compound [Cl-].C[N+](C)(C)C OKIZCWYLBDKLSU-UHFFFAOYSA-M 0.000 description 5
- CNKSJGOZVKNOBF-UHFFFAOYSA-N CCC(C(Cl)=C(CC)NC1=O)=C1C#N Chemical compound CCC(C(Cl)=C(CC)NC1=O)=C1C#N CNKSJGOZVKNOBF-UHFFFAOYSA-N 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- WUIQRWKAFUQURI-UHFFFAOYSA-N 4-chloro-2,6-dimethylheptane-3,5-dione Chemical compound CC(C)C(=O)C(Cl)C(=O)C(C)C WUIQRWKAFUQURI-UHFFFAOYSA-N 0.000 description 2
- RPLURORKBGUQEY-UHFFFAOYSA-N 4-chloroheptane-3,5-dione Chemical compound CCC(=O)C(Cl)C(=O)CC RPLURORKBGUQEY-UHFFFAOYSA-N 0.000 description 2
- TXFTZJRTBOIBEN-UHFFFAOYSA-N CCC(C)C(C(C(C(C)CC)=O)Cl)=O Chemical compound CCC(C)C(C(C(C(C)CC)=O)Cl)=O TXFTZJRTBOIBEN-UHFFFAOYSA-N 0.000 description 2
- YHDUUJJTDPGUQX-UHFFFAOYSA-N CCC(C)C(C(Cl)=C(C(C)CC)NC1=O)=C1C#N Chemical compound CCC(C)C(C(Cl)=C(C(C)CC)NC1=O)=C1C#N YHDUUJJTDPGUQX-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000003543 catechol methyltransferase inhibitor Substances 0.000 description 2
- 229960001701 chloroform Drugs 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 2
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- CEGGECULKVTYMM-UHFFFAOYSA-N 2,6-dimethylheptane-3,5-dione Chemical compound CC(C)C(=O)CC(=O)C(C)C CEGGECULKVTYMM-UHFFFAOYSA-N 0.000 description 1
- CJLGKQGYTBDGJZ-UHFFFAOYSA-N 3,7-dimethylnonane-4,6-dione Chemical compound CCC(C)C(=O)CC(=O)C(C)CC CJLGKQGYTBDGJZ-UHFFFAOYSA-N 0.000 description 1
- HWOPTKTWBBFODO-UHFFFAOYSA-N CC(C)C(C(C#N)=C(N=C1C(C)C)Cl)=C1Cl Chemical compound CC(C)C(C(C#N)=C(N=C1C(C)C)Cl)=C1Cl HWOPTKTWBBFODO-UHFFFAOYSA-N 0.000 description 1
- LCOAABNBVKMWAL-UHFFFAOYSA-N CC(C)C(C(Cl)=C(C(C)C)NC1=O)=C1C#N Chemical compound CC(C)C(C(Cl)=C(C(C)C)NC1=O)=C1C#N LCOAABNBVKMWAL-UHFFFAOYSA-N 0.000 description 1
- RIHAEZJPMJCUNQ-UHFFFAOYSA-N CCC(C(C#N)=C(N=C1CC)Cl)=C1Cl Chemical compound CCC(C(C#N)=C(N=C1CC)Cl)=C1Cl RIHAEZJPMJCUNQ-UHFFFAOYSA-N 0.000 description 1
- FSOLOYGFSBHRGK-UHFFFAOYSA-N CCC(C)C(C(C#N)=C(N=C1C(C)CC)Cl)=C1Cl Chemical compound CCC(C)C(C(C#N)=C(N=C1C(C)CC)Cl)=C1Cl FSOLOYGFSBHRGK-UHFFFAOYSA-N 0.000 description 1
- 229940099362 Catechol O methyltransferase inhibitor Drugs 0.000 description 1
- 229940081615 DOPA decarboxylase inhibitor Drugs 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000000534 dopa decarboxylase inhibitor Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- DGCTVLNZTFDPDJ-UHFFFAOYSA-N heptane-3,5-dione Chemical compound CCC(=O)CC(=O)CC DGCTVLNZTFDPDJ-UHFFFAOYSA-N 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229960004502 levodopa Drugs 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- PLPRGLOFPNJOTN-UHFFFAOYSA-N narcotine Natural products COc1ccc2C(OC(=O)c2c1OC)C3Cc4c(CN3C)cc5OCOc5c4OC PLPRGLOFPNJOTN-UHFFFAOYSA-N 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 238000000643 oven drying Methods 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229960002317 succinimide Drugs 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
- C07D213/85—Nitriles in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/584—Recycling of catalysts
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pyridine Compounds (AREA)
Abstract
The invention provides a preparation method of dichlorodialkyl nicotinonitrile, belonging to the technical field of chemical synthesis and comprising the following steps: performing chlorination reaction by using a compound I as a raw material and chlorine or N-chlorosuccinimide as a chlorination reagent to generate a compound II; carrying out condensation reaction on the compound II and cyanoacetamide under the action of alkali to generate a compound III; and carrying out chlorination reaction on the compound III and phosphorus oxychloride to generate the dichlorodialkyl nicotinonitrile. The preparation method of the invention avoids using sulfuryl chloride as a chlorinating agent, thereby avoiding the generation of sulfur dioxide tail gas and avoiding the corrosion of the generated acidic waste gas to equipment and the like.
Description
Technical Field
The invention belongs to the technical field of chemical synthesis, and particularly relates to a preparation method of dichlorodialkyl nicotinonitrile.
Background
The oligoprocone (opiane) is a drug developed by Portugal Bial-Portella pharmaceutical company, is a novel small chemical molecular entity, is a novel potent and selective catechol-O-methyltransferase inhibitor (COMT inhibitor), and can be clinically used for treating adult Parkinson's disease and patients with terminal symptom fluctuation by combining levodopa and a dopa decarboxylase inhibitor.
The key intermediate in the synthetic process of oppicapone is 2, 5-dichloro-4, 6-dimethylnicotinonitrile, and the synthetic route of 2, 5-dichloro-4, 6-dimethylnicotinonitrile is disclosed in the prior art (WO 2013/089573 a 1):
the method is characterized in that cyanoacetamide and acetylacetone are used as raw materials to carry out condensation reaction, and then chlorination reaction is carried out twice, wherein chlorination of C-H bonds is carried out by taking sulfonyl chloride as a chlorination reagent, and chlorination of C ═ O bonds is carried out by taking phosphorus oxychloride as a chlorination reagent.
In the process of implementing the invention, the inventors found that the above synthetic route has at least the following defects:
when C-H is chlorinated by taking sulfuryl chloride as a chlorinating agent, a large amount of sulfur dioxide and hydrogen chloride gas can be generated, and the generated sulfur dioxide gas cannot be effectively absorbed and utilized, so that waste gas pollution is caused.
Disclosure of Invention
Based on the background problems, the invention aims to provide a preparation method of dichlorodialkyl nicotinonitrile, which avoids using sulfuryl chloride as a chlorinating reagent, thereby reducing the production difficulty and reducing the output of acid waste gas.
In order to achieve the above object, the embodiment of the present invention provides the following technical solutions:
a method for preparing dichlorodialkyl nicotinonitrile comprises the following steps:
step I: performing chlorination reaction by using a compound I shown in a formula I as a raw material and using chlorine or N-chlorosuccinimide as a chlorination reagent to generate a compound II shown in a formula II;
step II: carrying out condensation reaction on the compound II and cyanoacetamide under the action of alkali to generate a compound III shown in a formula III;
step III: performing chlorination reaction on the compound III and phosphorus oxychloride to generate dichlorodialkyl nicotinonitrile shown as a formula IV;
wherein,
The R group is selected from one of methyl, ethyl, propyl, isopropyl and sec-butyl.
Further, in the step I, the mol ratio of the compound I to the chlorine gas/N-chlorosuccinimide is controlled to be 1: 1-1.1.
Furthermore, in the step I, when the chlorine is used as a chlorinating reagent to synthesize the compound II, the reaction temperature of the compound I and the chlorine is controlled to be 5-50 ℃, the reaction pressure is 1-2atm, and the reaction time is 3-5 h.
Further, in the step II, when the compound II reacts with cyanoacetamide, alcohol is used as a solvent; controlling the molar ratio of the cyanoacetamide to the compound II to be 1:1-1.1, and controlling the molar ratio of the base to the cyanoacetamide to be 0.04-0.06: 1.
Furthermore, in the step II, the reaction temperature of the compound II and the cyanoacetamide is controlled to be 50-75 ℃, and the reaction time is controlled to be 24-48 h.
Further, in the step III, the molar ratio of the compound III to the phosphorus oxychloride is controlled to be 1: 3.5-5.5.
Furthermore, the reaction temperature of the compound III and the phosphorus oxychloride is controlled to be 80-100 ℃, and the reaction time is 1.5-3.5 h.
Further, in the step III, when the compound III reacts with phosphorus oxychloride, a phase transfer catalyst is added, and the molar ratio of the phase transfer catalyst to the compound III is 0.45-0.55: 1.
Further, in the step III, after the reaction is finished, distilling the reaction liquid under reduced pressure until a solid I is separated out, and then dissolving the separated solid I in an organic solvent I to form a feed liquid;
and adding the feed liquid into water, stirring, standing, layering, washing the lower layer with water, distilling to separate out a solid II, adding the separated out solid II into an organic solvent II for dissolving, cooling, separating out the material, filtering, and leaching to obtain the dichlorodialkyl nicotinonitrile.
Compared with the prior art, the invention has the following effects:
1. the method takes the compound I as a raw material, takes chlorine or N-chlorosuccinimide (NCS) as a chlorination reagent to react to generate the compound II, and then carries out condensation reaction with cyanoacetamide to generate the compound III, thereby avoiding using sulfuryl chloride as a chlorination reagent, avoiding generating sulfur dioxide tail gas and avoiding corrosion of generated acid waste gas to equipment and the like.
2. When chlorine is used as a chlorination reagent, the excess unreacted chlorine can be completely absorbed by the alkaline solution and converted into sodium hypochlorite as a byproduct, so that the economic benefit is improved.
3. The invention controls the reaction temperature of the compound I and chlorine to regulate and control the reaction pressure, and when the temperature is higher than 50 ℃ and the pressure is higher than 2atm, polychlorinated impurities can be generated.
4. According to the invention, when the compound II reacts with cyanoacetamide, the excessive compound II is controlled, so that the reaction can be completely ensured.
5. When the compound III reacts with phosphorus oxychloride, the phosphorus oxychloride is used as a solvent, so that the molar ratio of the phosphorus oxychloride can be up to 5.5 times of that of the compound III, the phosphorus oxychloride after the reaction can be recycled, the reaction temperature of the compound III and the phosphorus oxychloride is controlled to be 80-100 ℃, and when the temperature is lower than 80 ℃, the reaction materials are difficult to completely dissolve.
Detailed Description
In order to solve the defect that a large amount of sulfur dioxide gas generated in the existing 2, 5-dichloro-4, 6-dimethylnicotinonitrile synthesis process is difficult to recycle, the embodiment of the invention provides a preparation method of dichlorodialkylnicotinonitrile, which takes a compound I as a raw material, takes chlorine or N-chlorosuccinimide (NCS) as a chlorination reagent to react to generate a compound II, and then carries out condensation reaction with cyanoacetamide to generate a compound III.
The invention will be elucidated by means of specific embodiments.
Example 1
The preparation method of the 2, 5-dichloro-4, 6-dimethylnicotinonitrile comprises the following steps:
step I: adding 1kg of acetylacetone (9.988mol, 1.0eq) into a 2L pressure reaction kettle, controlling the temperature of a reaction system to be 5 ℃ under the stirring condition, closing other valves of the reaction kettle, slowly introducing 708g of chlorine (9.988mol, 1.0eq) from a feed inlet, closing all the valves, heating, slowly increasing the pressure in the kettle along with the temperature rise, controlling the temperature to keep the pressure in the reaction kettle at 1atm, and reacting for 5 hours to generate 3-chloro-acetylacetone; the reaction is shown in equation (I):
monitoring the sampling gas phase, and after the reaction is finished, discharging the residual chlorine gas into a sodium hydroxide aqueous solution for absorption to obtain a sodium hypochlorite byproduct; the reaction yielded 1.249kg of product, reaction yield: 91.2%, gas phase purity: 98.1 percent.
The reaction product is sampled and subjected to nuclear magnetic hydrogen spectrum test, and the result is as follows: 1 HNMR.DELTA.2.5 (6H, s), 4.6(1H, s), from which it was found that the reaction product was indeed 3-chloro-acetylacetone.
Step II: in a 1L glass four-necked flask, 100g (1.189mol, 1.0eq) of cyanoacetamide, 160g (1.189mol, 1.0eq) of 3-chloro-acetylacetone, morpholine: 4.4g (0.05mol, 0.04eq) and 850g (26.53mol, 22.3eq) of methanol were stirred and heated, and the reaction was maintained at 50 ℃ for 48 hours, as shown in equation (II):
the liquid phase monitoring reaction is completed, the temperature is reduced to 10-15 ℃ after the reaction is finished, the filtration is carried out, and the methanol is leached to obtain 5-chloro-4, 6-dimethyl-3-cyanopyridone; and (5) drying to obtain a dry product: 200.5g, yield: 91.3%, liquid phase purity: 98.9 percent.
The reaction product is sampled and subjected to nuclear magnetic hydrogen spectrum test, and the result is as follows: 1HNMR,. delta.2.36 (3H, s), 2.41(3H, s,), 3.31(1H, brs), from which it was found that the reaction product was indeed 5-chloro-4, 6-dimethyl-3-cyanopyridinone.
Step III: in a 2L glass four-neck flask, 1675g of phosphorus oxychloride (10.924mol, 3.5eq) was added, and 5-chloro-4, 6-dimethyl-3-cyanopyridone was added with stirring: 570g (3.121mol, 1.0eq), tetramethylammonium chloride: 154g (1.40mol, 0.45eq), heated to 80 ℃ and reacted for 3.5h as shown in equation (III):
the thin layer shows that the raw material disappears, the raw material is distilled under reduced pressure, phosphorus oxychloride is evaporated until solid I is precipitated, the temperature is reduced, then 2500mL of dichloromethane is added, the mixture is stirred until the solid I is completely dissolved, and dichloromethane feed liquid is obtained, wherein in other embodiments, trichloromethane and dichloroethane can be used for replacing dichloromethane;
adding 1000ml of water into a 5L glass bottle, slowly pouring the dichloromethane feed liquid into the water while stirring, controlling the temperature to be 15-35 ℃, stirring and layering after all the dichloromethane feed liquid is added, washing the lower dichloromethane feed liquid with 200ml of water twice, then distilling and concentrating, and distilling under reduced pressure in the later period until solid II is separated out;
adding the solid II into 2300g of isopropanol to dissolve, wherein in other embodiments, the isopropanol can be replaced by methanol, ethanol, petroleum ether and n-heptane, cooling and separating the materials after complete dissolution, filtering at 0-5 ℃, leaching by precooled isopropanol to obtain a reaction product, and drying to obtain a product: 597g, yield: 94.5%, purity: 99.3 percent.
The reaction product is sampled and subjected to nuclear magnetic hydrogen spectrum test, and the result is as follows: 1HNMR,. delta.2.63 (3H, s), 2.68(3H, s), from which it is clear that the reaction product is indeed 2, 5-dichloro-4, 6-dimethylnicotinonitrile.
Example 2
The preparation method of the 2, 5-dichloro-4, 6-dimethylnicotinonitrile comprises the following steps:
step I: adding 1kg of acetylacetone (9.988mol, 1.0eq) into a 2L pressure reaction kettle, controlling the temperature of a reaction system to be 10 ℃ under the condition of stirring, closing other valves of the reaction kettle, slowly introducing 720g of chlorine (10.154mol, 1.02eq) from a feed inlet, closing all the valves, heating, slowly increasing the pressure in the kettle along with the temperature rise, controlling the temperature to keep the pressure in the reaction kettle at 1atm, and reacting for 5 hours to generate 3-chloro-acetylacetone;
monitoring the sampling gas phase, and after the reaction is finished, discharging the residual chlorine gas into a sodium hydroxide aqueous solution for absorption to obtain a sodium hypochlorite byproduct; after the reaction, 1.263kg of 3-chloro-acetylacetone was obtained, and the reaction yield was: 92.1%, gas phase purity: 98.0 percent.
Step II: in a 1L glass four-necked flask, 100g (1.189mol, 1.0eq) of cyanoacetamide, 172g (1.278mol, 1.07eq) of 3-chloro-acetylacetone, morpholine: 5.2g (0.06mol, 0.05eq) of ethanol 1221.3g (26.51mol, 22.3eq) are stirred, heated and reacted for 48 hours at 50 ℃;
the liquid phase monitoring reaction is completed, the temperature is reduced to 10-15 ℃ after the reaction is finished, the filtration is carried out, and the methanol is leached to obtain 5-chloro-4, 6-dimethyl-3-cyanopyridone; and (5) drying to obtain a dry product: 204.9g, yield: 93.1%, liquid phase purity: 98.7 percent.
Step III: in a 2L glass four-necked flask, 1800g of phosphorus oxychloride (11.739mol, 3.8eq) was added and 5-chloro-4, 6-dimethyl-3-cyanopyridone: 570g (3.121mol, 1.0eq), tetramethylammonium chloride: 171g (1.56mol, 0.5eq), heating to 85 ℃ and reacting for 3 h;
the post-treatment procedure after the end of the reaction was the same as in example 1, and 601.6g of the product was obtained after the end of the treatment, the product yield: 95.1%, product purity: 99.2 percent.
Example 3
The preparation method of the 2, 5-dichloro-4, 6-dimethylnicotinonitrile comprises the following steps:
step I: adding 1kg of acetylacetone (9.988mol, 1.0eq) into a 2L pressure reaction kettle, controlling the temperature of a reaction system to be 25 ℃ under the stirring condition, closing other valves of the reaction kettle, slowly introducing 720g of chlorine (10.154mol, 1.02eq) from a feed inlet, closing all the valves, heating, slowly increasing the pressure in the kettle along with the temperature rise, controlling the temperature to keep the pressure in the reaction kettle at 2atm, and reacting for 3h to generate 3-chloro-acetylacetone;
monitoring the sampling gas phase, and after the reaction is finished, discharging the residual chlorine gas into a sodium hydroxide aqueous solution for absorption to obtain a sodium hypochlorite byproduct; the reaction yielded 1.268kg of 3-chloro-acetylacetone, and the reaction yield was: 91.7%, gas phase purity: 97.2 percent.
Step II: in a 1L glass four-necked flask, 100g (1.189mol, 1.0eq) of cyanoacetamide, 172g (1.278mol, 1.07eq) of compound I, sodium hydroxide: 2.4g (0.06mol, 0.05eq) and 850g (26.51mol, 22.3eq) of methanol are stirred, heated and reacted for 36 hours at 65 ℃;
the liquid phase monitoring reaction is completed, the temperature is reduced to 10-15 ℃ after the reaction is finished, the filtration is carried out, and the methanol is leached to obtain 5-chloro-4, 6-dimethyl-3-cyanopyridone; oven drying to obtain dry product 207g, yield: 93.6%, liquid phase purity: 98.2 percent.
Step III: in a 2L glass four-necked flask, 1800g of phosphorus oxychloride (11.739mol, 3.8eq) was added and 5-chloro-4, 6-dimethyl-3-cyanopyridone: 570g (3.121mol, 1.0eq), tetrabutylammonium bromide: 503g (1.56mol, 0.5eq), heating to 90 ℃ and reacting for 2.5 h;
the post-treatment procedure after the completion of the reaction was the same as in example 1, and 596.5g of a product was obtained after the completion of the treatment, the product yield: 94.2%, product purity: 99.1 percent.
Example 4
The preparation method of the 2, 5-dichloro-4, 6-dimethylnicotinonitrile comprises the following steps:
step I: adding 1kg of acetylacetone (9.988mol, 1.0eq) into a 2L pressure reaction kettle, controlling the temperature of a reaction system to be 15 ℃ under the condition of stirring, closing other valves of the reaction kettle, slowly introducing 779g (10.987mol, 1.1eq) of chlorine gas from a feed inlet, closing all the valves, heating, slowly increasing the pressure in the kettle along with the temperature rise, controlling the temperature to keep the pressure in the reaction kettle at 1atm, and reacting for 5 hours to generate 3-chloro-acetylacetone;
monitoring the sampling gas phase, and after the reaction is finished, discharging the residual chlorine gas into a sodium hydroxide aqueous solution for absorption to obtain a sodium hypochlorite byproduct; after the reaction, 1.266kg of 3-chloro-acetylacetone was obtained, and the reaction yield was: 91.2%, gas phase purity: 96.8 percent.
Step II: in a 1L glass four-necked flask, 100g (1.189mol, 1.0eq) of cyanoacetamide, 176g (1.308mol, 1.1eq) of compound I, pyridine: 5.5g (0.07mol, 0.06eq) and 850g (26.51mol, 22.3eq) of methanol, stirring and heating, and keeping the temperature at 75 ℃ for reaction for 24 hours;
the liquid phase monitoring reaction is completed, the temperature is reduced to 10-15 ℃ after the reaction is finished, the filtration is carried out, and the methanol is leached to obtain 5-chloro-4, 6-dimethyl-3-cyanopyridone; and (5) drying to obtain a dry product: 204.6g, yield: 92.6%, liquid phase purity: 98.3 percent.
Step III: in a 2L glass four-necked flask, 1914g (12.484mol, 4eq) of phosphorus oxychloride was added, and 5-chloro-4, 6-dimethyl-3-cyanopyridinone was added with stirring: 570g (3.121mol, 1.0eq), tetramethylammonium chloride: 188g (1.716mol, 0.55eq), heating to 100 ℃, and reacting for 1.5 h;
the post-treatment procedure after the completion of the reaction was the same as in example 1, and 590.2g of a product was obtained after the completion of the treatment, the product yield: 93.3%, product purity: 99.2 percent.
Example 5
The preparation method of 2, 5-dichloro-4, 6-dimethylnicotinonitrile is different from the embodiment 2 in that N-chlorosuccinimide is taken as a chlorinating reagent, and the specific step I is as follows:
step I: in a 2L reaction flask, 150kg of acetylacetone (1.498mol, 1.0eq) were added and, with stirring, N-chlorosuccinimide: 204g (1.528mol, 1.02eq), and finally chloroform: 950ml, heating and refluxing for 5 hours, cooling to 0-5 ℃, filtering out succinimide, adding 500ml of water into the system, extracting and washing, layering, and concentrating and drying an organic phase to obtain a compound I: 177.4g, reaction yield: 88%, gas phase purity: 97.4 percent.
The rest of the reaction process is the same as example 2.
Example 6
A process for the preparation of 2, 5-dichloro-4, 6-diethylnicotinonitrile comprising the steps of:
step I: adding 1kg of 3, 5-heptanedione (7.812mol, 1.0eq) into a 2L pressure reaction kettle, controlling the temperature of a reaction system to be 10 ℃ under the condition of stirring, closing other valves of the reaction kettle, slowly introducing 565g of chlorine (7.968mol, 1.02eq) from a feed inlet, closing all the valves, heating, slowly increasing the pressure in the kettle along with the temperature rise, controlling the temperature to keep the pressure in the reaction kettle at 1atm, and reacting for 5 hours to generate 4-chloro-3, 5-heptanedione;
and (5) sampling gas phase monitoring, and after the reaction is finished, discharging the residual chlorine gas into a sodium hydroxide aqueous solution for absorption to obtain a sodium hypochlorite byproduct.
Step II: in a 1L glass four-necked flask, 100g (1.189mol, 1.0eq) of cyanoacetamide, 207.6g (1.278mol, 1.07eq) of 4-chloro-3, 5-heptanedione, morpholine: 5.2g (0.06mol, 0.05eq) of ethanol 1221.3g (26.51mol, 22.3eq) are stirred, heated and reacted for 48 hours at 50 ℃;
the liquid phase monitoring reaction is completed, the temperature is reduced to 10-15 ℃ after the reaction is finished, the filtration is carried out, and the methanol is leached to obtain 5-chloro-4, 6-diethyl-3-cyanopyridone; and drying to obtain a dry product.
Step III: in a 2L glass four-necked flask, 1800g of phosphorus oxychloride (11.739mol, 3.8eq) was added and 5-chloro-4, 6-diethyl-3-cyanopyridinone was added with stirring: 657.39g (3.121mol, 1.0eq), tetramethylammonium chloride: 171g (1.56mol, 0.5eq), heating to 85 ℃ and reacting for 3 h; the post-treatment process after the reaction is finished is the same as the method for preparing the 2, 5-dichloro-4, 6-dimethylnicotinonitrile.
Example 7
The preparation method of the 2, 5-dichloro-4, 6-diisopropyl nicotinonitrile comprises the following steps:
step I: adding 1kg of 2, 6-dimethyl-3, 5-heptanedione (6.4mol, 1.0eq) into a 2L pressure reaction kettle, controlling the temperature of a reaction system to be 10 ℃ under the stirring condition, closing other valves of the reaction kettle, slowly introducing 463g of chlorine (6.528mol, 1.02eq) from a feed inlet, closing all the valves, heating, slowly increasing the pressure in the kettle along with the temperature rise, controlling the temperature to keep the pressure in the reaction kettle at 1atm, and reacting for 5 hours to generate 4-chloro-2, 6-dimethyl-3, 5-heptanedione;
and (5) sampling gas phase monitoring, and after the reaction is finished, discharging the residual chlorine gas into a sodium hydroxide aqueous solution for absorption to obtain a sodium hypochlorite byproduct.
Step II: in a 1L glass four-necked flask, 100g (1.189mol, 1.0eq) of cyanoacetamide, 243.7g (1.278mol, 1.07eq) of 4-chloro-2, 6-dimethyl-3, 5-heptanedione, morpholine: 5.2g (0.06mol, 0.05eq) of ethanol 1221.3g (26.51mol, 22.3eq) are stirred, heated and reacted for 48 hours at 50 ℃;
the liquid phase monitoring reaction is completed, the temperature is reduced to 10-15 ℃ after the reaction is finished, the filtration is carried out, and the methanol is leached to obtain 5-chloro-4, 6-diethyl-3-cyanopyridone; and drying to obtain a dry product.
Step III: in a 2L glass four-necked flask, 1800g of phosphorus oxychloride (11.739mol, 3.8eq) was added and 5-chloro-4, 6-diisopropyl-3-cyanopyridone was added with stirring: 744.78g (3.121mol, 1.0eq), tetramethylammonium chloride: 171g (1.56mol, 0.5eq), heating to 85 ℃ and reacting for 3 h; the post-treatment process after the reaction is finished is the same as the method for preparing the 2, 5-dichloro-4, 6-dimethylnicotinonitrile.
Example 8
The preparation method of the 2, 5-dichloro-4, 6-di-sec-butyl nicotinonitrile comprises the following steps:
step I: adding 1kg of 3, 7-dimethyl-4, 6-nonanedione (5.4mol, 1.0eq) into a 2L pressure reaction kettle, controlling the temperature of a reaction system to be 10 ℃ under the stirring condition, closing other valves of the reaction kettle, slowly introducing 393g of chlorine (5.54mol, 1.02eq) from a feed inlet, closing all the valves, heating, slowly increasing the pressure in the kettle along with the temperature rise, controlling the temperature to keep the pressure in the reaction kettle at 1atm, and reacting for 5 hours to generate 5-chloro-3, 7-dimethyl-4, 6-nonanedione;
and (5) sampling gas phase monitoring, and after the reaction is finished, discharging the residual chlorine gas into a sodium hydroxide aqueous solution for absorption to obtain a sodium hypochlorite byproduct.
Step II: in a 1L glass four-necked flask, 100g (1.189mol, 1.0eq) of cyanoacetamide, 279.5g (1.278mol, 1.07eq) of 5-chloro-3, 7-dimethyl-4, 6-nonanedione, morpholine: 5.2g (0.06mol, 0.05eq) of ethanol 1221.3g (26.51mol, 22.3eq) are stirred, heated and reacted for 48 hours at 50 ℃;
the liquid phase monitoring reaction is completed, the temperature is reduced to 10-15 ℃ after the reaction is finished, the filtration is carried out, and the methanol is leached to obtain 5-chloro-4, 6-di-sec-butyl-3-cyanopyridone; and drying to obtain a dry product.
Step III: into a 2L glass four-necked flask, 1800g (11.739mol, 3.8eq) of phosphorus oxychloride was charged, and 832g (3.121mol, 1.0eq) of 5-chloro-4, 6-di-sec-butyl-3-cyanopyridinone was added under stirring: 171g (1.56mol, 0.5eq), heating to 85 ℃ and reacting for 3 h; the post-treatment process after the reaction is finished is the same as the method for preparing the 2, 5-dichloro-4, 6-dimethylnicotinonitrile.
It should be noted that, for those skilled in the art, various changes and modifications can be made without departing from the inventive concept of the present invention, and these changes and modifications belong to the protection scope of the present invention.
Claims (10)
1. The preparation method of dichlorodialkyl nicotinonitrile is characterized by comprising the following steps:
step I: performing chlorination reaction by using a compound I shown in a formula I as a raw material and using chlorine or N-chlorosuccinimide as a chlorination reagent to generate a compound II shown in a formula II;
step II: carrying out condensation reaction on the compound II and cyanoacetamide under the action of alkali to generate a compound III shown in a formula III;
step III: performing chlorination reaction on the compound III and phosphorus oxychloride to generate dichlorodialkyl nicotinonitrile shown as a formula IV;
wherein,
2. The method according to claim 1, wherein the R group is selected from the group consisting of methyl, ethyl, propyl, isopropyl, and sec-butyl.
3. The method for producing dichlorodialkylnicotinonitrile according to claim 1, wherein in the step I, the molar ratio of the compound I to chlorine gas/N-chlorosuccinimide is controlled to 1:1 to 1.1.
4. The method according to claim 3, wherein the reaction temperature of the compound I with chlorine gas is controlled to 5 to 50 ℃, the reaction pressure is controlled to 1 to 2atm, and the reaction time is controlled to 3 to 5 hours when the compound II is synthesized using chlorine gas as a chlorinating agent in step I.
5. The method for producing dichlorodialkylnicotinonitrile according to claim 1, wherein in the step II, the compound II is reacted with cyanoacetamide using an alcohol as a solvent; controlling the molar ratio of the cyanoacetamide to the compound II to be 1:1-1.1, and controlling the molar ratio of the base to the cyanoacetamide to be 0.04-0.06: 1.
6. The method according to claim 5, wherein the reaction temperature of the compound II with cyanoacetamide in the step II is controlled to 50 to 75 ℃ and the reaction time is controlled to 24 to 48 hours.
7. The process according to claim 1, wherein the molar ratio of the compound III to phosphorus oxychloride in the step III is controlled to be 1:3.5 to 5.5.
8. The method according to claim 7, wherein the reaction temperature of the compound III with phosphorus oxychloride is controlled to 80 to 100 ℃ and the reaction time is 1.5 to 3.5 hours.
9. The method according to claim 1, wherein in step III, a phase transfer catalyst is added during the reaction of the compound III with phosphorus oxychloride, and the molar ratio of the phase transfer catalyst to the compound III is 0.45-0.55: 1.
10. The method according to claim 1, wherein in step III, after the reaction is completed, the reaction solution is distilled under reduced pressure to precipitate a solid I, and the precipitated solid I is dissolved in an organic solvent I to form a feed solution;
and adding the feed liquid into water, stirring, standing, layering, taking the lower layer, washing with water, distilling until a solid II is separated out, adding the separated solid II into an organic solvent II for dissolving, cooling, separating out the material, filtering, and leaching to obtain the dichlorodialkyl nicotinonitrile.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110667044.XA CN113292489B (en) | 2021-06-16 | 2021-06-16 | Preparation method of dichlorodialkyl nicotinonitrile |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110667044.XA CN113292489B (en) | 2021-06-16 | 2021-06-16 | Preparation method of dichlorodialkyl nicotinonitrile |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113292489A true CN113292489A (en) | 2021-08-24 |
CN113292489B CN113292489B (en) | 2022-08-30 |
Family
ID=77328433
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110667044.XA Active CN113292489B (en) | 2021-06-16 | 2021-06-16 | Preparation method of dichlorodialkyl nicotinonitrile |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113292489B (en) |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003057674A1 (en) * | 2001-12-28 | 2003-07-17 | Bayer Pharmaceuticals Corporation | 4-sulfide / sulfoxide / sulfonyl-1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor |
CN101429082A (en) * | 2008-09-08 | 2009-05-13 | 华东师范大学 | Method for quick synthesis of alpha-single chloro-ketone compounds |
WO2012005805A1 (en) * | 2010-05-07 | 2012-01-12 | Glaxosmithkline Llc | Azaindazoles |
WO2013067302A1 (en) * | 2011-11-04 | 2013-05-10 | Glaxosmithkline Intellectual Property (No. 2) Limited | Method of treatment |
CN104066718A (en) * | 2011-04-13 | 2014-09-24 | Epizyme股份有限公司 | Substituted benzene compounds |
CN104080769A (en) * | 2011-04-13 | 2014-10-01 | Epizyme股份有限公司 | Aryl- or heteroaryl-substituted benzene compounds |
US20140350057A1 (en) * | 2011-12-13 | 2014-11-27 | Bial - Portela & Ca, S.A. | Chemical compound useful as intermediate for preparing a catechol-o-methyltransferase inhibitor |
CN105418548A (en) * | 2015-12-11 | 2016-03-23 | 大连世慕化学有限公司 | Microreactor used for alpha-position hydrogen atom chlorination of alpha-dicarbonyl compound and synthesis method |
US20180370958A1 (en) * | 2017-06-27 | 2018-12-27 | Azad Pharmaceutical Ingredients Ag | Route Of Synthesis For Opicapone |
-
2021
- 2021-06-16 CN CN202110667044.XA patent/CN113292489B/en active Active
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003057674A1 (en) * | 2001-12-28 | 2003-07-17 | Bayer Pharmaceuticals Corporation | 4-sulfide / sulfoxide / sulfonyl-1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor |
CN101429082A (en) * | 2008-09-08 | 2009-05-13 | 华东师范大学 | Method for quick synthesis of alpha-single chloro-ketone compounds |
WO2012005805A1 (en) * | 2010-05-07 | 2012-01-12 | Glaxosmithkline Llc | Azaindazoles |
CN104066718A (en) * | 2011-04-13 | 2014-09-24 | Epizyme股份有限公司 | Substituted benzene compounds |
CN104080769A (en) * | 2011-04-13 | 2014-10-01 | Epizyme股份有限公司 | Aryl- or heteroaryl-substituted benzene compounds |
WO2013067302A1 (en) * | 2011-11-04 | 2013-05-10 | Glaxosmithkline Intellectual Property (No. 2) Limited | Method of treatment |
US20140350057A1 (en) * | 2011-12-13 | 2014-11-27 | Bial - Portela & Ca, S.A. | Chemical compound useful as intermediate for preparing a catechol-o-methyltransferase inhibitor |
CN105418548A (en) * | 2015-12-11 | 2016-03-23 | 大连世慕化学有限公司 | Microreactor used for alpha-position hydrogen atom chlorination of alpha-dicarbonyl compound and synthesis method |
US20180370958A1 (en) * | 2017-06-27 | 2018-12-27 | Azad Pharmaceutical Ingredients Ag | Route Of Synthesis For Opicapone |
Non-Patent Citations (1)
Title |
---|
SZABO, MONIKA 等: "A structure–activity relationship study of the positive allosteric modulator LY2033298 at the M4 muscarinic acetylcholine receptor.", 《MEDCHEMCOMM》, vol. 6, no. 11, 30 September 2015 (2015-09-30), pages 1998 - 2003 * |
Also Published As
Publication number | Publication date |
---|---|
CN113292489B (en) | 2022-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101503375B (en) | Method for synthesizing methoxy amine hydrochlorate | |
TWI684587B (en) | Process for the preparation of 4-alkoxy-3-hydroxypicolinic acids | |
CN114262311A (en) | Synthesis method of intermediate alpha-chloroacetyl-gamma-butyrolactone and synthesis method of thiathiazole | |
CN113372288A (en) | Synthetic method of topramezone pesticide intermediate | |
CN113292489B (en) | Preparation method of dichlorodialkyl nicotinonitrile | |
CN102875463B (en) | Synthesis method for high-quality and low-cost bispyrithione | |
CN107469828A (en) | A kind of core shell structure support type tungsten composite catalyst and its preparation method and application | |
DK2298756T3 (en) | Process for the preparation of 3-methyl-2-thiophenecarboxylic acid | |
CN117417333A (en) | Synthesis process of pyribenzoxim sulfone | |
CN109627183B (en) | Preparation method of chloroacetaldehyde oxime | |
CN114685253A (en) | Preparation method of prothioconazole intermediate 3, 5-dichloro-2-pentanone | |
CN117142954A (en) | Preparation method of ethyl 4, 4-trifluoroacetoacetate | |
CN112939922B (en) | Synthesis method of 1-cyano-6-methylsulfonyl-7-nitro-9H-xanthene-9-ketone | |
CN112939893A (en) | Synthesis method of 4- (4-aminophenyl) -3-morpholinone | |
CN113845502A (en) | Preparation method of 3- (benzyloxy) -4-oxo-4H-pyran-2-carboxylic acid | |
CN113968792A (en) | Novel method for synthesizing 2-chloro-5-aminophenol | |
CN113563337B (en) | Preparation method of camelning alkali A | |
CN114315588B (en) | Preparation method of o-nitrobenzaldehyde | |
CN113717096B (en) | Preparation method of 2-chloropyridine | |
CN111592471B (en) | Method for synthesizing cephalosporin active ester intermediate through bromination reaction | |
CN116063184A (en) | Preparation method of 2-bromo-6-fluoroaniline | |
CN118388562A (en) | Improved method of clindamycin hydrochloride alcoholate synthesis process | |
CN113735693B (en) | Synthesis method of resveratrol dimethyl ether | |
CN116606227A (en) | Synthetic method of CLT acid | |
CN114736133B (en) | Preparation of 2,4, 5-trifluoro-3-methoxybenzoic acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |